You Searched For "gilead sciences stock" and got 20 results
Sort By:
2 mins read
Wall Street says buy stocks that pay dividends with $6 trillion of cash ready to be deployed
"We see more opportunities within equities for investors searching for yield," Bank of America's Sa…
Matthew Fox
2 mins read
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
2 mins read
Gilead slides 4% after COVID-19 drug shows limited benefit in moderately ill patients
Patients who received remdesivir for five days were 65% more likely to show signs of recovery than …
Saloni Sardana
2 mins read
Immunomedics soars 106% after Gilead agrees to acquire the cancer-drug company for $21 billion
Gilead expects the deal to immediately bolster its revenue growth, and to be neutral to accretive t…
Matthew Fox
2 mins read
Gilead surges 17% on report that drug shows effectiveness against COVID-19
In a Chicago hospital, all patients with Covid-19 treated with Gilead's Remdesivir were discharged …
Carmen Reinicke
2 mins read
Dow surges 500 points on optimism around US economic reopening plan
Positive results reported from Gilead's coronavirus treatment trials offered new optimism around an…
Ben Winck
2 mins read
Pharmaceutical giants have added $51 billion to their market value in 2020 as they scramble to develop a coronavirus vaccine
Gilead Sciences was the frontrunner among 6 pharma companies helped by its trials of the antiviral …
Shalini Nagarajan
2 mins read
Gilead tanks 9% on report its coronavirus drug doesn't help patients
The report contained "inappropriate characterizations," Gilead said, adding that low enrollment led…
Ben Winck
2 mins read
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
1 min read
Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall
Regeneron's antibody cocktail COVID-19 treatment is set to begin clinical trials over the summer, w…
Carmen Reinicke
1 min read
Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug
One of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID…
Andrew Dunn
1 min read
Study results for a leading potential coronavirus treatment were accidentally released by the WHO and then taken down
About 14% of severe coronavirus patients taking the drug remdesivir died compared to 13% who got a …
Andrew Dunn
2 mins read
The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it's charging up to $520 a vial for remdesivir
Governments of developed countries will pay $2,340 for a five-day course of the antiviral drug remd…
Andrew Dunn
2 mins read
Gilead Sciences spikes after human trials start on a possible coronavirus treatment
China's coronavirus has so far killed more than 360 and infected more than 17,000 people around the…
Carmen Reinicke
2 mins read
Mega-cap tech stocks have gotten so big that the Nasdaq 100 is about to undergo a 'special rebalance' to address overconcentration
There are seven potential winners of the Nasdaq 100 shake up, including Starbucks, Gilead Sciences,…
Matthew Fox
3 mins read
Global stocks are surging after pharmaceutical giant Gilead said it's making progress on a drug to treat coronavirus
"I agree that most of the countries are about to see their coronavirus peak, but massive damage has…
Saloni Sardana
3 mins read
Stock picks for a Biden victory
Business Insider's biggest healthcare stories for August 5.
Kimberly Leonard
3 mins read
The US government's supply of remdesivir — the only drug proved to treat the coronavirus — is due to run out at the end of June
The number of US COVID-19 patients requiring remdesivir outnumbers available stocks by two to one, …
Bill Bostock
1 min read
Gilead just made a $4.9 billion bet on cancer-drug maker Forty Seven, whose stock skyrocketed 62%
Best known for its treatments for conditions like HIV and hepatitis C, Foster City, California-base…
Lydia Ramsey
2 mins read
Noida-based Jubilant inks packs with Gilead to produce, sell remdesivir
The pact allows Jubilant to register, manufacture and sell remdesivir in 127 countries, includin…